CoStasis Stops Bleeding At Hard And Soft Tissue Sites - Cohesion PMA Study
This article was originally published in The Gray Sheet
Executive Summary
Cohesion Technologies plans to file a premarket approval application this spring for its CoStasis surgical hemostat for treatment of bleeding in cardiovascular, hepatic, general and orthopedic surgery procedures, the firm announced Jan. 14.